Sarina Tanimoto

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Jan 25	SPRY ARS Pharmaceuticals	Stock Option Common Stock	Grant	Acquire A	Yes	No	10.71	767,600	8.22 mm	767,600
2 Jan 25	SPRY ARS Pharmaceuticals	Stock option Common Stock	Grant	Acquire A	No	No	10.71	261,900	2.80 mm	261,900
17 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	Yes	Yes	11.6705	50,000	583.53 k	1,098,499
17 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	Yes	Yes	11.6715	50,000	583.58 k	1,297,447
10 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	Yes	Yes	13.1631	50,000	658.16 k	1,148,499
10 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	Yes	Yes	13.1653	50,000	658.27 k	1,246,494
6 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Option exercise	Acquire M	Yes	No	8.42	11,876	100.00 k	4,327,189
6 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	8.42	11,876	100.00 k	3,433,512
6 Dec 24	SPRY ARS Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	1.44	13,789	19.86 k	3,421,636
6 Dec 24	SPRY ARS Pharmaceuticals	Stock Option Common Stock	Option exercise	Dispose M	Yes	No	8.42	11,876	100.00 k	1,088,124

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.